
浏览全部资源
扫码关注微信
1.400010 重庆, 重庆医科大学附属第二医院肝胆外科
2.400042 重庆, 第三军医大学大坪医院野战外科研究所第一研究室, 创伤、烧伤与复合伤国家重点实验室
龚建平, E-mail: gongjianping11@126.com Gong Jianping, E-mail: gongjianping11@126.com
纸质出版日期:2017-1-30,
收稿日期:2016-8-5,
录用日期:2016-10-6
扫 描 看 全 文
陈浩, 范霞, 孙宇, 等. 吴茱萸碱对酵母多糖诱导急性腹膜炎小鼠的保护作用[J]. 第三军医大学学报, 2017,39(2):163-168.
Hao Chen, Xia Fan, Yu Sun, et al. Protective effect of evodiamine on zymosan-induced acute peritonitis in mice[J]. J Third Mil Med Univ, 2017,39(2):163-168.
陈浩, 范霞, 孙宇, 等. 吴茱萸碱对酵母多糖诱导急性腹膜炎小鼠的保护作用[J]. 第三军医大学学报, 2017,39(2):163-168. DOI: 10.16016/j.1000-5404.201608031.
Hao Chen, Xia Fan, Yu Sun, et al. Protective effect of evodiamine on zymosan-induced acute peritonitis in mice[J]. J Third Mil Med Univ, 2017,39(2):163-168. DOI: 10.16016/j.1000-5404.201608031.
目的
2
探讨吴茱萸碱(evodiamine,EVO)对酵母多糖(zymosan,ZYM) 诱导的小鼠腹膜炎中炎症反应及中性粒细胞(polymorphonuclear neutrophil,PMN)浸润的影响。
方法
2
将54只成年雄性C57BL/6小鼠按随机数字表法分为正常对照组、模型组和EVO治疗组。模型组腹腔注射1 mg/mL ZYM溶液(1 mL)建立急性腹膜炎小鼠模型,EVO治疗组则同时腹腔注射10 mg/kg EVO及1 mg/mL ZYM溶液,正常对照组腹腔注射等量磷酸盐缓冲液。各组处理后2、6、12 h处死6只小鼠,收集眼眶血及腹腔灌洗液。采用酶联免疫吸附法检测血清及腹腔灌洗液中白介素6(interleukin-6
IL-6)、肿瘤坏死因子α(tumor necrosis factor-α
TNF-α)、角化细胞来源趋化因子(keratinocyte-derived chemokine
KC)及巨噬细胞炎性蛋白2(macrophage inflammatory protein 2
MIP-2)的含量;通过血细胞计数板计数腹腔灌洗液中混合细胞总数;利用流式细胞仪检测腹腔灌洗液中PMN比例及PMN中活性氧(reactive oxygen species,ROS)水平;采用Western blot检测6 h时腹腔灌洗液混合细胞中核转录因子-kB (nuclear factor-κB,NF-κB)p65入核情况。
结果
2
建模后2、6、12 h,模型组血清及腹腔灌洗液中IL-6、TNF-α、KC及MIP-2含量均高于正常对照组(
P
<0.05),EVO治疗组上述指标均较模型组明显降低(
P
<0.05),其中,血清中IL-6、KC及MIP-2均于2 h达高峰,随后逐渐下降,而TNF-α在2 h逐渐上升,6 h达到高峰,随后逐渐下降;腹腔灌洗液中TNF-α、KC及MIP-2均于2 h达高峰,随后逐渐下降,而IL-6在2 h逐渐上升,6 h达到高峰,随后逐渐下降。制模后6 h,EVO治疗组可显著降低腹腔混合细胞数与PMN数及其百分比(
P
<0.05),且PMN中ROS显著降低(
P
<0.05)。另EVO治疗可显著降低腹腔混合细胞中细胞核的NF-κB p65表达(
P
<0.05)。
结论
2
EVO可抑制ZYM诱导急性小鼠腹膜炎模型中血清及腹腔灌洗液中炎症因子及趋化因子的分泌,减轻腹腔PMN的浸润,并抑制PMN中ROS的产生,该作用可能是通过抑制NF-kB p65入核实现的。
Objective
2
To determine the effect of evodiamine (EVO) on zymosan(ZYM)-induced acute peritonitis in mice and explore its mechanism.
Methods
2
Fifty-four adult male C57BL/6 mice were randomly divided into control group (phosphate buffer saline+10% dimethyl sulphoxide)
model group (ZYM 50 mg/kg +10% dimethyl sulphoxide)
and EVO treatment group (EVO 10 mg/kg+ZYM 50 mg/kg)
and the drugs were administered by intraperitoneal injection. Six mice in each group were sacrificed at 2
6 and 12 h respectively after the injection. Blood samples and peritoneal lavage fluid (PLF) were collected. The levels of interleukin-6 (IL-6)
tumor necrosis factor-α (TNF-α)
keratinocyte-derived chemokine (KC) and macrophage inflammatory protein 2 (MIP-2) in the serum and PLF were measured by enzyme linked immunosorbent assay (ELISA). The numbers of leukocytes and polymorphonuclear neutrophil (PMN) in PLF were determined by hemocytometry and flow cytometry
respectively. The level of reactive oxygen species (ROS) in PMN was also detected by flow cytometry. The protein expression of nuclear factor-κB p65 (NF-κB p65) in the leukocytes was analyzed by Western blotting.
Results
2
After ZYM injection
the levels of IL-6
TNF-α
KC and MIP-2 in the serum and PLF were significantly elevated at 2
6 and 12 h (
P
<0.05)
while EVO treatment could dramatically reduce the levels of all the cytokines and chemokines (all
P
<0.05). The serum levels of IL-6
KC and MIP-2 reached the peak in 2 h and then declined gradually. While that of TNF-α was elevated in 2 h and got the summit in 6 h
followed by slow reduction. The PLF levels of above cytokines and chemokines were in similiar trends as in the serum. Furthermore
EVO could notably reduce the numbers of ZYM-induced inflammatory cells and PMN in the PLF(
P
<0.05)
and reduce the percentage of PMN and its ROS level at 6 h(
P
<0.05). Western blot results showed that EVO treatment could down-regulate the NF-κB p65 expression in peritoneal inflammatory cells.
Conclusion
2
EVO can effectively alleviate ZYM-induced peritoneal inflammatory injury in the mice through reducing the secretion of cytokines and chemokines
inhibiting the infiltration of leukocytes and neutrophils
decreasing the percentage of neutrophils and ROS production
and down-regulating NF-κB p65 expression in the nuclei.
吴茱萸碱急性腹膜炎酵母多糖中性粒细胞浸润
evodiamineacute peritonitiszymosanpolymorphonuclear neutrophil infiltration
Newson J, Stables M, Karra E, et al. Resolution of acute inflammation bridges the gap between innate and adaptive immunity[J]. Blood, 2014,124(11): 1748-1764.DOI: 10.1182/blood-2014-03-562710
Singer M, Deutschman C S, Seymour C W, et al. The third international consensus definitions for sepsis and septicshock (sepsis-3) [J]. JAMA, 2016, 315(8): 801-810. DOI: 10.1001/jama.2016.0287
Matsuda N, Takatani Y, Higashi T, et al. Severe infection in critical emergency care[J]. Nihon Rinsho, 2016, 74(2): 245-251.
Monroe L L, Armstrong M G, Zhang X, et al. Zymosan-induced peritonitis: effects on cardiac function, temperature regulation, translocation of bacteria and role of dectin-1[J]. Shock, 2016. [Epub ahead of print]. DOI: 10.1097/SHK.dsjydxxb-39-2-16300669
Talreja D, Singh P K, Kumar A. In vivo role of TLR2 and MyD88 signaling in eliciting innate immune responses in staphylococcal endophthalmitis[J]. Invest Ophthalmol Vis Sci, 2015, 56(3): 1719-1732. DOI: 10.1167/iovs.14-16087
Lerman Y V, Kim M. Neutrophil migration under normal and sepsis conditions[J]. Cardiovasc Hematol Disord Drug Targets, 2015, 15(1): 19-28.
Cash J L, White G E, Greaves D R. Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation[J]. Methods Enzymol,2009,461: 379-396. DOI: 10.1016/S0076-6879(09)05417-2
Kobayashi Y. Effects of evodiamine, a major alkaloid of Goshuyu (Evodia Fruits), on TRPV1[J]. Nihon Yakurigaku Zasshi, 2015,146(3): 135-139. DOI: 10.1254/fpj.146.135
Hu C, Gao X, Han Y, et al. Evodiamine sensitizes BGC-823 gastric cancer cells to radiotherapy in vitro and in vivo[J]. Mol Med Rep,2016,14(1): 413-419. DOI: 10.3892/mmr.2016.5237
Chen T C, Chien C C, Wu M S, et al. Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells[J]. Phytomedicine, 2016, 23(1): 68-78. DOI: 10.1016/j.phymed.2015.12.003
Gavaraskar K, Dhulap S, Hirwani R R. Therapeutic and cosmetic applications of Evodiamine and its derivatives—A patent review[J]. Fitoterapia, 2015,106: 22-35. DOI: 10.1016/j.fitote.2015.07.019
Takada Y, Kobayashi Y, Aggarwal B B. Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion[J]. J Biol Chem, 2005, 280(17): 17203-17212.DOI: 10.1074/jbc.M500077200
Liu Y N, Pan S L, Liao C H, et al. Evodiamine represses hypoxia-induced inflammatory proteins expression and hypoxia-inducible factor 1alpha accumulation in RAW264.7[J]. Shock, 2009, 32(3): 263-269.DOI: 10.1097/SHK.0b013e31819940cb
Lv Q, Xue Y, Li G, et al. Beneficial effects of evodiamine on P2X(4)-mediated inflammatory injury of human umbilical vein endothelial cells due to high glucose[J]. Int Immunopharmacol, 2015, 28(2): 1044-1049. DOI: 10.1016/j.intimp.2015.08.020
Hu Y, Mao A, Yu Z, et al. Anti-endotoxin and anti-inflammatory effects of Chinese herbal medicinal alkaloid ingredients in vivo[J]. Microb Pathog, 2016, 99: 51-55.DOI: 10.1016/j.micpath.2016.08.006
Ren X, Wang L, Wu X. A potential link between TSLP/TSLPR/STAT5 and TLR2/MyD88/NFκB-p65 in human corneal epithelial cells for Aspergillus fumigatus tolerance[J]. Mol Immunol, 2016, 71: 98-106. DOI: 10.1016/j.molimm.2015.12.014
Rosas E C, Correa L B, Pádua T A, et al. Anti-inflammatory effect of Schinus terebinthifolius Raddi hydroalcoholic extract on neutrophil migration in zymosan-induced arthritis[J]. J Ethnopharmacol, 2015, 175: 490-498. DOI: 10.1016/j.jep.2015.10.014
Lai X, Huang X, Zeng Y. Protective effect of anhydroicaritin against peritonitis in mice[J]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2013, 29(10): 1036-1039.
Zhang T Z, Yang S H, Yao J F, et al. Sangxingtang inhibits the inflammation of LPS-induced acute lung injury in mice by down-regulating the MAPK/NF-κB pathway[J]. Chin J Nat Med, 2015,13(12): 889-895. DOI: 10.1016/S1875-5364(15)30094-7
Hung N D, Kim M R, Sok D E. Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis[J]. Br J Pharmacol, 2011, 162(5): 1119-1135. DOI: 10.1111/j.1476-5381.2010.01117.x
Kovach M A, Standiford T J. The function of neutrophils in sepsis[J]. Curr Opin Infect Dis, 2012, 25(3): 321-327. DOI: 10.1097/QCO.0b013e3283528c9b
Su Y, Richmond A. Chemokine Regulation of Neutrophil Infiltration of Skin Wounds[J]. Adv Wound Care (New Rochelle), 2015, 4(11): 631-640. DOI: 10.1089/wound.2014.0559
Watzlawick R, Kenngott E E, Liu F D, et al. Anti-Inflammatory Effects of IL-27 in Zymosan-Induced Peritonitis: Inhibition of Neutrophil Recruitment Partially Explained by Impaired Mobilization from Bone Marrow and Reduced Chemokine Levels[J]. PLoS One, 2015, 10(9): e0137651. DOI: 10.1371/journal.pone.0137651.eCollection2015
0
浏览量
0
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621